Collegium Pharmaceutical, Inc.

Climate Impact & Sustainability Data (2022)

Investing in clean-in-place manufacturing systems, enabling wastewater to be recycled and thereby reducing freshwater consumption.
Packaging products in recyclable materials.
Repurposing unneeded information technology equipment through donations to STEM education non-profits, thereby reducing the impact of electronic waste.
Implementing two manufacturing process improvement initiatives that reduce processing time, resulting in decreased energy consumption.
Implementing in-office processes to minimize the use of consumables such as paper and plastic cups.
Operating under a hybrid model where employees are in the office part-time, thereby reducing car emissions associated with employee commuting.

Maintained excellent employee engagement (92% survey completion rate).
Initiated implementation of a multi-year Diversity, Equity, and Inclusion (DEI) strategic plan.
Donated over $350,000 to STEM initiatives and charities providing clothing and food.

Board of Directors provides guidance on strategic priorities and receives quarterly updates on ESG progress.
Executive Committee responsible for strategic oversight and implementation of ESG.
Employee-led Working Group discusses ESG prioritization and implementation.

Exploring options to reduce the impact of our sales fleet, and to integrate hybrid and electric vehicles into our fleet as a strategic priority.
Developing an action plan to ensure active monitoring of resource use throughout the value chain and reviewing financial implications of environmental risks.

Vendor Code of Conduct (includes environmental, human rights, health and safety, and business ethics considerations).